Font Size: a A A
Keyword [Treatment-resistant]
Result: 41 - 58 | Page: 3 of 3
41. Part One. The pharmacogenetics of treatment resistant depression. Part Two. DNA interaction and photocleavage by di- and tetracationic intercalants
42. Psychological flexibility, rumination, and avoidance as predictors of outcome in cognitive behavioral therapy for treatment-resistant major depressive disorde
43. Using network analysis to identify factors differentiating antipsychotic treatment-resistant and treatment-responsive patients with psychosis
44. Bortezomib For The Intervention Of Treatment-resistant Anti-NMDAR Encephalitis
45. The Clinical And Brain Mechanism Study Of Transcutaneous Auricular Vagus Nerve Stimulation For Treating The Treatment Resistant Depression Using BOLD/MRS Multimodal FMRI
46. Magnetic Seizure Therapy And Electroconvulsive Therapy For Ultra-treatment-resistant Schizophrenia: A Parallel Control Pilot Study
47. The Level Of Baseline Cognition And Early Clinical Improvement Of Treatment Resistant Depression Predict The Therapeutic Outcome Of Electroconvulsive Therapy
48. Study Of Plasma Non-enzyme Antioxidants And Thyroid Hormone Levels And Cognitive Levels In Patients With Treatment-resistant Depression
49. Resting State Functional Magnetic Resonance Imaging Of Treatment-resistant Depression Before And After Electroconvulsive Therapy Based On ReHo And FC
50. Therapeutic Effects And Brain Functional Mechanisms Of Nitrous Oxide On Patients With Treatment-resistant Depression
51. A Voxel-Based Morphometry Study Of Patients With Treatment-Resistant Depression Before And After Electroconvulsive Therapy
52. Characteristics Of Clinical Pathology And Cognitive Impairment In Treatment Resistant Patients With Schizophrenia
53. Efficacy And Safety Of Electroacupuncture Combined With LF-rTMS In The Treatment Of Treatment Resisdant Depression
54. The Role And Mechanism Of High Mobility Group Box 1 In Cortical Dysplasia-associated Epilepsy
55. Prevalence And Influencing Factors Of Apparent Treatment-Resistant Hypertension In Patient With Peritoneal Dialysis
56. The Study Of Glutamate Receptor Antibody Levels In Treatment Resistant Schizophrenia
57. Dual-target Accelerated RTMS For Treatment-resistant Depression Study On The Effect Of Curative Effect And Resting-state Functional Connection
58. Network Meta-analysis Of Escitalopram Combined With Other Drugs In The Treatment Of Refractory Depressio
  <<First  <Prev  Next>  Last>>  Jump to